HomeCRISIL › Filing
🔔 Get instant alerts when CRISIL files quarterly results on BSE Start free trial →
CRISIL Limited (CRISIL)

Please find enclosed Investor presentation.

Filed: 21 Jul 2026, 22:43 IST Exchange: BSE Category: Financial Results — Investor Presentation
AI summary - Q2 FY26 income from operations grew 28.8% y-y; profit before tax up 24.4% y-y - Crisil Ratings revenue up 21.4% y-y; segment profit margin improved to 44.3% - Research, Analytics & Solutions segment income rose 30.1% y-y; margin expanded to 20.4% - Interim dividend declared at Rs 10 per share in Q2 FY26 - Business momentum driven by strong demand in Corporate and Investment Banking, credit lending solutions, and data analytics - Macro outlook: India GDP growth forecast at 6.6% for FY27 with inflation at 5.1% - Crisil Foundation expanded rural financial inclusion impacting 2.65 lakh people - Continued focus on AI upgrades and domain-led product innovation to enhance client experience
Source: Original filing PDF — view on exchange portal
⚡ You're reading this after the fact — subscribers got it instantly
ISA
Indian Stock Alerts BOT
🚨 CRISIL — Quarterly Results
Revenue: ₹2,35,800 Cr (+12% YoY)
PAT: ₹19,200 Cr (+17% YoY)
EBITDA margin: 16.8%
Board declared ₹10/share dividend. Jio adds 8M subs.
✓✓ 6:47 PM
🎧
Instant audio summaries2-min AI concall recap delivered with every earnings alert
📊
20-quarter financialsRevenue, PAT, EBITDA, margins — auto-extracted from filings
🔍
Forensic red-flag screenAudit, governance, accruals & RPT flags scored automatically
Instant Telegram alertsResults, board meetings, insider trades — within minutes

Add CRISIL to your watchlist — all of this, automated.

Sign in with Google
14-day Pro trial · No credit card · Cancel anytime

More on CRISIL Limited

Important. The summary above is generated automatically from CRISIL Limited's own public regulatory filing under SEBI LODR. Indian Stock Alerts is not a SEBI-registered Research Analyst or Investment Adviser. This page is informational, not investment advice, a recommendation to buy or sell any security, or any opinion about the company's business, governance or financial health. Always read the original filing before acting and consult a registered adviser for investment decisions.